Your browser doesn't support javascript.
loading
Nitrogen-Walk Approach to Explore Bioisosteric Replacements in a Series of Potent A2B Adenosine Receptor Antagonists.
Mallo-Abreu, Ana; Prieto-Díaz, Rubén; Jespers, Willem; Azuaje, Jhonny; Majellaro, Maria; Velando, Carmen; García-Mera, Xerardo; Caamaño, Olga; Brea, José; Loza, María I; Gutiérrez-de-Terán, Hugo; Sotelo, Eddy.
Afiliação
  • Jespers W; Department of Cell and Molecular Biology, Uppsala University, Uppsala SE 75124, Sweden.
  • Brea J; Centro Singular de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
  • Loza MI; Centro Singular de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
  • Gutiérrez-de-Terán H; Department of Cell and Molecular Biology, Uppsala University, Uppsala SE 75124, Sweden.
J Med Chem ; 63(14): 7721-7739, 2020 07 23.
Article em En | MEDLINE | ID: mdl-32573250
ABSTRACT
A systematic exploration of bioisosteric replacements for furan and thiophene cores in a series of potent A2BAR antagonists has been carried out using the nitrogen-walk approach. A collection of 42 novel alkyl 4-substituted-2-methyl-1,4-dihydrobenzo[4,5]imidazo[1,2-a]pyrimidine-3-carboxylates, which contain 18 different pentagonal heterocyclic frameworks at position 4, was synthesized and evaluated. This study enabled the identification of new ligands that combine remarkable affinity (Ki < 30 nM) and exquisite selectivity. The structure-activity relationship (SAR) trends identified were substantiated by a molecular modeling study, based on a receptor-driven docking model and including a systematic free energy perturbation (FEP) study. Preliminary evaluation of the CYP3A4 and CYP2D6 inhibitory activity in optimized ligands evidenced weak and negligible activity, respectively. The stereospecific interaction between hA2BAR and the eutomer of the most attractive novel antagonist (S)-18g (Ki = 3.66 nM) was validated.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Receptor A2B de Adenosina / Antagonistas do Receptor A2 de Adenosina / Imidazóis Limite: Animals / Humans Idioma: En Revista: J Med Chem Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Receptor A2B de Adenosina / Antagonistas do Receptor A2 de Adenosina / Imidazóis Limite: Animals / Humans Idioma: En Revista: J Med Chem Ano de publicação: 2020 Tipo de documento: Article